Nan‐Yung Hsu
- Cancer Research top 10%
- MicroRNA in disease regulation 4
- Neurology top 10%
- Myasthenia Gravis and Thymoma 4
-
- Lung Cancer Diagnosis and Treatment 6
- Lung Cancer Treatments and Mutations 5
-
- Lung Cancer Research Studies 4
-
- RNA modifications and cancer 5
- DNA Repair Mechanisms 3
-
- Medical Imaging Techniques and Applications 3
- Co-authors
- Chung-Ping HsuChih‐Yi ChenKuan‐Chih ChowTze‐Yi LinLiang-Shun WangChih‐Shiun ShihChih-Yi ChenChun‐Ming Tsai
- Journals
- The Lancet (1 paper)SHILAP Revista de lepidopterología (1 paper)Cancer Research (3 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Nan‐Yung Hsu
42 papers receiving 810 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 178
- Neurology 120
- Pulmonary and Respiratory Medicine 228
- Oncology 167
- Immunology and Allergy 32
Countries citing papers authored by Nan‐Yung Hsu
This map shows the geographic impact of Nan‐Yung Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan‐Yung Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan‐Yung Hsu more than expected).
Fields of papers citing papers by Nan‐Yung Hsu
This network shows the impact of papers produced by Nan‐Yung Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan‐Yung Hsu. The network helps show where Nan‐Yung Hsu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nan‐Yung Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 39 | |
| 2 | 2014 | 29 | |
| 3 | 2013 | 3 | |
| 4 | 2013 | 10 | |
| 5 | 2010 | 8 | |
| 6 | Cortactin overexpression in the esophageal squamous cell carcinoma and its involvement in the carcinogenesis | 2007 | 1 |
| 7 | 2007 | 61 | |
| 8 | 2006 | 6 | |
| 9 | 2006 | 11 | |
| 10 | 2004 | 1 | |
| 11 | 2004 | 55 | |
| 12 | 2003 | 9 | |
| 13 | 2002 | 1 | |
| 14 | 2002 | 7 | |
| 15 | 2002 | 5 | |
| 16 | 2000 | 9 | |
| 17 | 1997 | 2 | |
| 18 | 1997 | 24 | |
| 19 | 1996 | 9 | |
| 20 | 1994 | 1 |
About Nan‐Yung Hsu
Nan‐Yung Hsu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Hepatology, having authored 44 papers that have together received 822 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (5 papers), RNA modifications and cancer (5 papers), MicroRNA in disease regulation (4 papers), Myasthenia Gravis and Thymoma (4 papers), Lung Cancer Research Studies (4 papers), Medical Imaging Techniques and Applications (3 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Cancer Research (178 citations), Neurology (120 citations) and Pulmonary and Respiratory Medicine (228 citations). Nan‐Yung Hsu has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Chung-Ping Hsu, Chih‐Yi Chen, Kuan‐Chih Chow, Tze‐Yi Lin, Liang-Shun Wang, Chih‐Shiun Shih, Chih-Yi Chen, Chun‐Ming Tsai, Chung‐Ping Hsu and Chang-Fang Chiu. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.